News

ilS on Twitter and Linkedin

You can now follow all of ilS latest news on Twitter (www.twitter.com/ilsintelligence). We also have a company profile page on LinkedIn (www.linkedin.com/company/insights-in-life-sciences).

 


Challenges of Personalized Medicine

Key Progress and Future Challenges of Personalized Medicine


Current pain management in Spanish hospitals

Current Pain Management in Spanish Hospitals and Future Challenges


ilS gets ENISA funding

ilS is proud to announce we have been granted Spanish ENISA funding in December 2012.


ilS presence at Bio-Europe Spring® 2013

ilS successfully presented its services in the 7th Annual International Partnering Company Bio-Europe Spring® 2013. The event welcomed 1.219 large biotech and pharma companies, financiers and innovative start-ups from 50 different countries.


ilS selected for BioemprendedorXXI

ilS is delighted to announce we have been selected for the BioemprendedorXXI programme.



ilS presence at EMIG® 2013

ilS presented a series of cases in order to demonstrate the ways ilS has been able to guide intelligent decision making of companies in the sector.


Insights from the NICE Guidelines for Osteoporosis

Insights from the NICE Technology Appraisal Guidance for Osteoporosis treatment


2013 in numbers

2013 in Numbers: ilS has worked with 52 Countries and 1.600 Experts. Also, 110 Interviews and 90 Surveys have been conducted


ilS opens office in London

ilS is delighted to announce the opening of their first office in London! The office will be located in 9 Devonshire, Sq and will start running by next February this year.


ilS celebrates its first ilS Speaker Series

ilS celebrated last Friday 7th of March its first ilS Speaker Series (SM) focused in drug Price and Reimbursement criteria in the UK and Spain.


ilS Speaker Series - P&R criteria in the UK

Insights from our first ils Speaker Series focusing on P&R criteria in the UK (Presentation only in Spanish)


ilS has been selected finalist for the Emprendedor XXI Prize

The ilS Team is glad to announce the Company has been selected as finalist for the Catalonia Emprendedor XXI prize (La Vanguardia 27/05/2014).


Case studies and sample deliverables

ilS has access to the world’s top Life Sciences Experts and will guide you through the Expert consultation process: selecting the right expertise, formulating the specific questions to be addressed and analyzing the information collected.


ilS was invited by the British Consul-General

From left to right:
Dr. Pepi Hurtado (ilS Partner); Dr. Itziar Escudero (ilS Partner); Mr. Andrew Gwatkin (British Consul-General)


ilS has participated in the event

From left to right:
Dr. Itziar Escudero (ilS partner), Dr. Xavier Trias (Barcelona Mayor), Mr. Jordi Joly (Economy, Business & Employment CEO), Mr. David Darsch (CEO Collaborative Forum Founder)


ilS Conference Participation 2014

ilS Conference attendance in 2014.


ilS raises funds to open up to US Market and stenghten its online platform of Life Sciences Experts.

INSIGHTS IN LIFE SCIENCES (ilS), the first company with an online platform of international Life Sciences Experts, ilS NetworkSM, that offers comprehensive and value added solutions to its clients, ilS SolutionsSM, has closed a funding round of €195,000.


ilS reaches an agreement with the College of Physicians of Lugo

ilS has signed an agreement with the Official College of Physicians of Lugo in order to continue increasing the number of medical specialists affiliated to the online platform of experts (ilS NetworkSM), a global network of life sciences experts that counts with key opinion leaders from Europe, USA, LATAM and Asia. 


ilS Newsletter - September 2014

Look at our latest Newsletter.


ilS has attended the BIOSPAIN 2014 Congress and has sponsored the #XacoBIO Saint James Way

INSIGHTS IN LIFE SCIENCES (ilS) has attended the BIOSPAIN 2014 Congress, an International Biotechnology meeting of reference in Spain, which was held from the 24th to the 26th of September in Santiago de Compostela (Spain), and has counted with ilS as the sponsor for the #XacoBIO.


ilS signs a Collaboration Agreement with the Molecular Biology Center "Severo Ochoa" (CBMSO)

INSIGHTS IN LIFE SCIENCES (ilS) has signed an agreement with the Molecular Biology Center "Severo Ochoa" (CBMSO) in order to continue increasing the number of biomedical researchers affiliated to the experts network ilS NetworkSM.


ilS Newsletter - October 2014

Look at our latest Newsletter.


The newspaper "Heraldo de Aragon" interviews Insights in Life Sciences (ilS) partners

The article, published online on November 1st (http://goo.gl/w3gJYa), highlights the relevance that has acquired the Market Access department nowadays for ensuring pharmaceutical companies are able to launch their products to the market.


Insights in Life Sciences (ilS) participates in the First International Economy and Health Forum focused in Improving the Future of the Health Sector in Spain

The Economy and Health Foundation (http://fundacioneconomiaysalud.org) organized the First International Economy and Health Forum entitled "100 Perspectives for improving the Health Sector", counting with Dr. Itziar Escudero, ilS partner, as an expert in Life Sciences.


Insights in Life Sciences (ilS) attends the Biopharma Mexico 2014 Conference

ilS has attended this event with a dual objective: On the one hand, to continue strengthening ties with LATAM life sciences experts, key members of ilS global network ilS NetworkSM, and moreover, to be up-to-date with the latest trends in Biosimilars progress in this region, one of the key topics discussed during the Conference, and of particular interest for ilS.


ilS participated in #BLEandHealth: “Innovation as a transformer of the Health Sector” event

Tuesday December 2nd, Insights in Life Sciences (ilS) participated in BLEandHealth as a leading start-up company in the Life Sciences sector.




Insights in Life Sciences (ilS) attended Genesis 2014, the most relevant Life Sciences conference in London

Dr. Pepi Hurtado, partner at ilS, and Laura Gabarró, consultant at the new ilS office in the UK, attended last Tuesday December 9th to the Genesis 2014 conference in London.


Medicamentos Biológicos ASEBIO

ilS collaborated with ASEBIO in the development of an article focused in biologics that was presented at the Spanish Minister of Health (document in Spanish only).


ilS collaborated with ASEBIO in the development of an article focused in biologics that was presented at the Spanish Minister of Health

Insights in Life Sciences (ilS) collaborated with ASEBIO developing a paper about biologics, which was presented last Tuesday November 25th at the Spanish Ministry of Health (MSSSI), during the 1st Europabio-ASEBIO meeting, focused in innovation and biologics based therapies. 


Insights in Life Sciences (ils) inaugurates its new Office in Madrid

Insights in Life Sciences (ilS) inaugurates a new office in Madrid, in alignment with its expansion plan for this year. The new office –located in the elegant neighborhood of El Viso in Madrid- is already ilS second office in Spain (beside the one in Barcelona) and adds to the one in London (UK), which has been operative for a year now.


ilS in Numbers

Insights in Life Sciences (ilS) initiates the new year with the satisfaction of having accomplished its objectives during 2014. And our milestones can be translated into numbers.


ilS Specialist in Primary Studies

Insights in Life Sciences (ilS) is a consultancy firm with broad experience in performing Primary Studies with globally renowned experts in the Life Sciences field. In contrast to Secondary Studies, to perform Primary Studies the source of knowledge is directly accessed first-hand by means of in-depth telephone interviews, online surveys or on-site advisory boards or focus groups. ilS is specialized in the use of the different existing techniques needed to perform such studies.


ilS Newsletter - January 2015

Look at our latest Newsletter.


ilS presents the Second Edition of ilS Speaker Series(SM) focused this year on Rare Diseases

Although Rare Diseases are those that affect a small number of the population (5 out of 10,000 inhabitants), only in Spain there are more than 3 million people affected by this condition. For that reason ilS has decided to focus the Second Edition of its ilS Speaker SeriesSM on this subject.


ilS celebrated its Second Edition of the ilS Speaker Series(SM)

The Second Edition of ilS Speaker SeriesSM, which was focused on Rare Diseases, was celebrated last Friday April 27th in Madrid. Under the tilte: "Orphan Drugs: How to Speed Up their Access to Patients with Rare Diseases?" ilS Speaker Series laid the grounds to discuss about the patient and market needs in regards to Rare Diseases and Orphan Drugs.


Market access for diagnostic tests ASEBIO

ilS coordinated jointly with ASEBIO a white paper focused on the current market access situation for in vitro diagnostic tests in the European Union (document in Spanish only).



ilS Newsletter - January 2017

Look at our latest Newsletter


ilS Newsletter - June 2017

Look at our latest Newsletter.


Contact Us

If you have any questions or want to know more about ilS, please fill the form below or send us an email to: info.es@ilsintelligence.com

I accept the Privacy Policy



Check our latest news
  • ilS Newsletter - June 2017

    Look at our latest Newsletter.

  • ilS Newsletter - January 2017

    Look at our latest Newsletter

  • ilS celebrated its Second Edition of the ilS Speaker Series(SM)

    The Second Edition of ilS Speaker SeriesSM, which was focused on Rare Diseases, was celebrated last Friday April 27th in Madrid. Under the tilte: "Orphan Drugs: How to Speed Up their Access to Patients with Rare Diseases?" ilS Speaker Series laid the grounds to discuss about the patient and market needs in regards to Rare Diseases and Orphan Drugs.

  • ilS presents the Second Edition of ilS Speaker Series(SM) focused this year on Rare Diseases

    Although Rare Diseases are those that affect a small number of the population (5 out of 10,000 inhabitants), only in Spain there are more than 3 million people affected by this condition. For that reason ilS has decided to focus the Second Edition of its ilS Speaker SeriesSM on this subject.

  • ilS Newsletter - January 2015

    Look at our latest Newsletter.

  • ilS Specialist in Primary Studies

    Insights in Life Sciences (ilS) is a consultancy firm with broad experience in performing Primary Studies with globally renowned experts in the Life Sciences field. In contrast to Secondary Studies, to perform Primary Studies the source of knowledge is directly accessed first-hand by means of in-depth telephone interviews, online surveys or on-site advisory boards or focus groups. ilS is specialized in the use of the different existing techniques needed to perform such studies.


See all news



join_us

Join our expert network

If you are interested in joining our global Life Sciences expert network, please send an email to ilS@ilsintelligence.com